From: An approach to measure compliance to clinical guidelines in psychiatric care
Implementation clinics | Control clinics | |
---|---|---|
Indicator | OR(CI95%) | OR(CI95%) |
Accessibility/wait time | 2.2(1.0–4.7) | 0.6(0.3–1.4) |
Diagnostic assessment | 7.9(2.3–27.8) | 1.2(0.4–3.6) |
Diagnostic instrument | 2.7(1.4–5.4) | * |
Standardized rating scale | 6.2(2.9–13.2) | 0.7(0.3–1.4) |
Standardized rating scale during treatment | 7.1(3.7–13.7) | 1.9(0.9–4.1) |
Substance/drug abuse | 8.1(4.2–15.7) | 2.9(1.3–6.6) |
Treatment (care) plan | 4.9(2.5–9.5) | 0.9(0.4–1.9) |
Evaluation/outcome | 12.4(4.7–32.9) | 0.8(0.4–1.7) |
Continuity | 5.6(2.2–14.2) | 0.4(0.2–1.0) |
Suicide assessment | 34.7(13.2–91.4) | 0.6(0.3–1.3) |
Antidepressant medication | 8.5(4.2–17.5) | 0.7 (0.3–1.4) |
t-value, p-value | t-value, p-value | |
Total score | 16.2, 0.001 | ns |